Caspofungin affects adhesion of Candida to a human cell line

Journal de Mycologie Medicale

Volumn 17, Issue 1, 2007, Pages 1-7

  Kyselgof, G ^a   Sandovsky Losica, H ^a   Berdicevsky, I ^b   Segal, E ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Adhesion; Candida; Caspofungin; Human cell line

Indexed keywords

CASPOFUNGIN; FLUORESCEIN ISOTHIOCYANATE; GLUCAN; TRYPAN BLUE;

ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CELL ADHESION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; FLUOROMETRY; FUNGICIDAL ACTIVITY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; KERATINOCYTE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SCANNING ELECTRON MICROSCOPE;

CANDIDA; CANDIDA ALBICANS;

EID: 33947172811     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mycmed.2006.12.003     Document Type: Article

References (28)

1. Abu-el Teen K., Ghannum M., and Stretton RJ. Effects of sub-inhibitory concentrations of antifungal agents on adherence of Candida spp. to buccal epithelial cells in vitro. Mycoses 32 (1989) 551-562
2. Appleton S.S. Candidiasis: pathogenesis, clinical characteristics and treatment. J Calif Dent Assoc 28 (2000) 942-948
3. Blash J.L. Systemic Candida infections in patients with leukemia: an overview of drug therapy. Clin J Oncol Nurs 6 (2002) 323-331
4. Boucher H.W., Groll A.H., Chiou C.C., and Walsh T.J. Newer systemic antifungal agents: pharmacokinetics safety and efficacy. Drugs 64 (2004) 1997-2020
5. Braga P.C., Maci S., Dal Sasso M., Piatti G., and Bohn M. Experimental evidence for a role of sub-inhibitory concentrations of rilopirox nystatin and fluconazole on adherence of Candida spp. to vaginal epithelial cells. Chemotherapy 42 (1996) 259-265
6. Cerca N., Martins S., Pier G.B., Oliveira R., and Azeredo J. The relationship between inhibition of bacterial adhesion to a solid surface by sub-MIC of antibiotics and subsequent development of a biofilm. Res Microbiol 156 (2005) 650-655
7. Cotter G., and Kavanagh K. Adherence mechanisms of Candida albicans. Br J Biomed Sci 57 (2000) 241-249
8. Denning D.W. Echinocandin antifungal drugs. Lancet 362 (2003) 1142-1151
9. Edwards Jr. J.E. Candida species. In: Mandell G.L., Bennet J.E., and Dolin R. (Eds). Principles and practice of infectious diseases. Sixth edition (2005), Churchill Livingstone, Philadelphia 2939-2957
10. Ellepola A.N., and Samaranayake L.P. The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion. Oral Dis 4 (1998) 260-267
11. Ellepola A.N., Panagoda G.J., and Samaranayake L.P. Adhesion of oral Candida species to human buccal epithelial cells following brief exposure to nystatin. Oral Microbiol Immunol 14 (1999) 358-363
12. Kabha K., Schmegner J., Keisari Y., Parolis H., Schlepper-Schaefer J., and Ofek I. SP-A enhances phagocytosis of Klebsiella by interaction with capsular polysaccharides and alveolar macrophages. Am J Physiol 272 (1997) L344-L352
13. Mavor A.L., Thewes S., and Hube B. Systemic fungal infections caused by Candida species: epidemiology, infection process and virulence attributes. Curr Drug Targets 5 (2005) 863-864
14. McCormack P.L., and Perry C.M. Caspofungin: a review of its use in the treatment of fungal infections. Drugs 65 (2005) 2049-2068
15. NCCLS, Reference Method for broth Dilution Antifungal Susceptibility Testing of Yeasts (M27-A); Approved Standard-Second Edition. Wayne, Pennsylvania 2002.
16. Ofek I., and Doyle R.J. Principles of bacterial adhesion. Bacterial Adhesion to Cells and Tissues (1994), Chapman & Hall, NY & London p. 1-15
17. Reid G., and Sobel J.D. Bacterial adherence in the pathogenesis of urinary tract infections: a review. Rev Infect Dis 9 (1987) 470-487
18. Rolston K. Overview of systemic fungal infections. Oncology (Williston Park) 15 Suppl 9 (2001) 11-14
19. Sandovsky-Losica H., and Segal E. Infection of HEp2 epithelial cells with Candida albicans: adherence and post adherence events. FEMS Immunol Med Microbiol 46 (2006) 470-475
20. Segal E., and Sandovsky-Losica H. Interaction of Candida albicans with mammalian tissues in vitro and in vivo. In: Doyle R.J., and Ofek I. (Eds). Methods in Enzymology (1995), Academic Press, San Diego 439-452
21. Segal E. Inhibitors of Candida albicans adhesion to prevent candidiasis. In: Kahane I., and Ofek I. (Eds). Toward anti-adhesion therapy for microbial diseases (1996), Plenum Press, New York & London 197-206
22. Segal E., and Sandovsky-Losica H. Basis for Candida albicans adhesion and prevention. In: Jacobs P.H., and Nall L. (Eds). Fungal Diseases (1997), Marcel Decker, New York 321-334
23. Segal E., Trygerman O., Gov Y., Sandovsky-Losica H., and Berdicevsky I. Adhesion of Candida albicans to epithelial cells: Effect of antimycotics. J Med Mycol 7 (1997) 71-76
24. Segal E., Gottlieb S., Altboum Z., Gov Y., and Berdicevsky I. Adhesion of Candida albicans to epithelial cells: Effect of Nikkomycin. Mycoses 40 (1997) 33-39
25. Soustre J., Rodier M.H., Imbert-Bouyer S., Daniault G., and Imbert C. Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins. J Antimicrob Chemother 53 (2004) 522-525
26. Vazquez J.A. Anidulafungin: a new echinocandin with a novel profile. Clin Ther 27 (2005) 657-673
27. Yano J., Lilly E.A., Steele C., Fortenberry D., and Fidel P.L.Jr. Oral and vaginal epithelial cell ani-Candida activity is acid labile and does not require live epithelial cells. Oral Microbiol Immunol 20 (2005) 199-205
28. Zhanel G.G., and Nicolle L.E. Effect of subinhibitory antimicrobial concentrations (sub MIC) on in vitro bacterial adherence to uroepithelial cells. J Antimicrob Chemother 29 (1992) 617-627